BioCentury
ARTICLE | Financial News

Morphosys amends NASDAQ listing

April 13, 2018 5:20 PM UTC

MorphoSys AG (Xetra:MOR; Pink:MPSYY) amended its proposed NASDAQ listing on April 9 and now plans to raise about $200 million through the sale of 8.3 million ADSs at $24.12 in a follow-on underwritten by Goldman Sachs, J.P. Morgan, Leerink, Berenberg and JMP...

BCIQ Company Profiles

MorphoSys AG